Cerebras Systems Inc. CBRS
—
206.75
0.34
0.16%
as of 25 Sep
- Market cap
- $47.2B
- P/E
- 93.5×
Follow CBRS
| Jun '26 | Mar '26 | Dec '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
99.91 | 99.91 | — | 99.91 |
+1 more quarter Free account |
P/S ratio |
57.89 | 0.00 | — | 0.00 | |
P/FCF ratio |
0.00 | 0.00 | — | 0.00 | |
P/Operating CF |
(557.71) | 1,583.87 | — | 1,583.87 | |
P/B ratio |
3.64 | 0.00 | — | 0.00 | |
Price to Tangible BV |
3.64 | 0.00 | — | 0.00 | |
EV/Sales |
44.97 | 0.00 | — | 0.00 | |
EV/EBITDA |
0.00 | 0.00 | — | 0.00 | |
EV/Operating CF |
(151.28) | 0.00 | — | 0.00 | |
EV/FCF |
(28.63) | 0.00 | — | 0.00 | |
Quick Ratio |
5.57 | 2.33 | 1.93 | — | |
Current Ratio |
5.82 | 2.51 | 2.15 | — | |
Net Debt/EBITDA |
18.22 | (367.82) | 0.00 | 0.00 | |
Debt/Assets |
9.98% | 27.31% | 15.24% | 0.00% | |
Debt/Equity |
0.13 | 0.49 | 0.26 | — | |
Asset Turnover |
0.10 | — | — | — | |
Operating CF/Net income |
0.13 | (0.88) | — | (0.57) | |
Capex/Depreciation |
(6.07) | (6.52) | — | (16.07) | |
Interest Coverage |
0.00 | 0.00 | — | 0.00 | |
Research and Development Expense of Revenue |
177.75% | 39.03% | — | 58.81% | |
Selling, General and Administrative Expense of Revenue |
101.41% | 13.30% | — | 27.60% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
209.32% | 4.96% | — | 12.85% | |
Graham Net Nets |
0.20 | 0.07 | — | 0.07 | |
Graham Number |
54.94 | 0.00 | — | 0.00 | |
Earnings Yield |
1.00% | 1.00% | — | 1.00% | |
Free Cash Flow Yield |
(2.71%) | 0.00% | — | 0.00% | |
Revenue per Share |
1.19 | 3.08 | — | 1.96 | |
Operating CF per Share |
(0.40) | 0.20 | — | (1.31) | |
Capex per Share |
(2.76) | (2.10) | — | (1.65) | |
Free Cash Flow per Share |
(3.16) | (1.90) | — | (2.95) | |
Cash per Share |
57.01 | 51.92 | 0.00 | 0.00 | |
Shareholders Equity per Share |
60.64 | 43.83 | 0.00 | 0.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
60.64 | 43.83 | 0.00 | 0.00 | |
Free Cash Flow |
(476.73) | (119.63) | — | (155.76) | |
Working Capital |
7,555.63 | 2,153.72 | 824.11 | — | |
Capital Expenditures |
(416.90) | (131.97) | — | (86.85) | |
Net Current Asset Value |
6,648.48 | 1,385.28 | 572.30 | — | |
EV/EBIT |
0.00 | 0.00 | — | 0.00 | |
Capex to Sales |
2.31 | 0.68 | — | 0.84 | |
Net Profit Margin |
(250.14%) | (7.24%) | — | 116.45% | |
Price to Operating Income |
0.00 | 0.00 | — | 0.00 | |
| Other line items | |||||
Average Assets |
5,813.94 | — | — | — |
Columns are period end dates · fundamentals updated 24 Sep 2026